Research programme: liver disorders therapy - NicOx

Drug Profile

Research programme: liver disorders therapy - NicOx

Alternative Names: Liver disorders therapy research programme - NicOx; NCX 999

Latest Information Update: 16 May 2007

Price : $50

At a glance

  • Originator NicOx
  • Class
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Liver disorders

Most Recent Events

  • 09 Jun 2004 Preclinical trials in Liver disorders in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top